These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12911546)

  • 1. Endothelin-1 receptor blockade prevents renal injury in experimental hypercholesterolemia.
    Chade AR; Best PJ; Rodriguez-Porcel M; Herrmann J; Zhu X; Sawamura T; Napoli C; Lerman A; Lerman LO
    Kidney Int; 2003 Sep; 64(3):962-9. PubMed ID: 12911546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of proteasome inhibition on the kidney in experimental hypercholesterolemia.
    Chade AR; Herrmann J; Zhu X; Krier JD; Lerman A; Lerman LO
    J Am Soc Nephrol; 2005 Apr; 16(4):1005-12. PubMed ID: 15716331
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endothelin-a receptor blockade improves renal microvascular architecture and function in experimental hypercholesterolemia.
    Chade AR; Krier JD; Textor SC; Lerman A; Lerman LO
    J Am Soc Nephrol; 2006 Dec; 17(12):3394-403. PubMed ID: 17082239
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct renal injury in early atherosclerosis and renovascular disease.
    Chade AR; Rodriguez-Porcel M; Grande JP; Krier JD; Lerman A; Romero JC; Napoli C; Lerman LO
    Circulation; 2002 Aug; 106(9):1165-71. PubMed ID: 12196346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid-lowering-independent effects of simvastatin on the kidney in experimental hypercholesterolaemia.
    Wilson SH; Chade AR; Feldstein A; Sawamura T; Napoli C; Lerman A; Lerman LO
    Nephrol Dial Transplant; 2003 Apr; 18(4):703-9. PubMed ID: 12637638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Angiotensin II AT1 receptor blockade improves renal perfusion in hypercholesterolemia.
    Chade AR; Rodriguez-Porcel M; Rippentrop SJ; Lerman A; Lerman LO
    Am J Hypertens; 2003 Feb; 16(2):111-5. PubMed ID: 12559676
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathways of renal fibrosis and modulation of matrix turnover in experimental hypercholesterolemia.
    Chade AR; Mushin OP; Zhu X; Rodriguez-Porcel M; Grande JP; Textor SC; Lerman A; Lerman LO
    Hypertension; 2005 Oct; 46(4):772-9. PubMed ID: 16172424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal vascular function in hypercholesterolemia is preserved by chronic antioxidant supplementation.
    Stulak JM; Lerman A; Porcel MR; Caccitolo JA; Romero JC; Schaff HV; Napoli C; Lerman LO
    J Am Soc Nephrol; 2001 Sep; 12(9):1882-1891. PubMed ID: 11518781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of renal structural alterations in combined hypercholesterolemia and renal artery stenosis.
    Chade AR; Rodriguez-Porcel M; Grande JP; Zhu X; Sica V; Napoli C; Sawamura T; Textor SC; Lerman A; Lerman LO
    Arterioscler Thromb Vasc Biol; 2003 Jul; 23(7):1295-301. PubMed ID: 12750121
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endothelin type A receptor antagonism restores myocardial perfusion response to adenosine in experimental hypercholesterolemia.
    Bonetti PO; Best PJ; Rodriguez-Porcel M; Holmes DR; Lerman LO; Lerman A
    Atherosclerosis; 2003 Jun; 168(2):367-73. PubMed ID: 12801621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beneficial effects of antioxidant vitamins on the stenotic kidney.
    Chade AR; Rodriguez-Porcel M; Herrmann J; Krier JD; Zhu X; Lerman A; Lerman LO
    Hypertension; 2003 Oct; 42(4):605-12. PubMed ID: 12925565
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin prevents renal injury and expression of lactin-like oxidized low-density lipoprotein receptor-1 in rabbits with hypercholesterolemia.
    Yu YH; Wang Y; Dong B; Sun SZ; Chen Y; Meng XH; Liu ZZ
    Chin Med J (Engl); 2005 Apr; 118(8):621-6. PubMed ID: 15899115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin-A receptor blockade slows the progression of renal injury in experimental renovascular disease.
    Kelsen S; Hall JE; Chade AR
    Am J Physiol Renal Physiol; 2011 Jul; 301(1):F218-25. PubMed ID: 21478482
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of acute and chronic antioxidant interventions in experimental renovascular disease.
    Chade AR; Krier JD; Rodriguez-Porcel M; Breen JF; McKusick MA; Lerman A; Lerman LO
    Am J Physiol Renal Physiol; 2004 Jun; 286(6):F1079-86. PubMed ID: 14722019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute inhibition of the endogenous xanthine oxidase improves renal hemodynamics in hypercholesterolemic pigs.
    Daghini E; Chade AR; Krier JD; Versari D; Lerman A; Lerman LO
    Am J Physiol Regul Integr Comp Physiol; 2006 Mar; 290(3):R609-15. PubMed ID: 16284087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chronic endothelin receptor antagonism prevents coronary vasa vasorum neovascularization in experimental hypercholesterolemia.
    Herrmann J; Best PJ; Ritman EL; Holmes DR; Lerman LO; Lerman A
    J Am Coll Cardiol; 2002 May; 39(9):1555-61. PubMed ID: 11985922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of renal cortical neovascularization in experimental hypercholesterolemia.
    Chade AR; Krier JD; Galili O; Lerman A; Lerman LO
    Hypertension; 2007 Oct; 50(4):729-36. PubMed ID: 17635852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vascular responses in vivo to 8-epi PGF(2alpha) in normal and hypercholesterolemic pigs.
    Krier JD; Rodriguez-Porcel M; Best PJ; Romero JC; Lerman A; Lerman LO
    Am J Physiol Regul Integr Comp Physiol; 2002 Aug; 283(2):R303-8. PubMed ID: 12121841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioxidant intervention prevents renal neovascularization in hypercholesterolemic pigs.
    Chade AR; Bentley MD; Zhu X; Rodriguez-Porcel M; Niemeyer S; Amores-Arriaga B; Napoli C; Ritman EL; Lerman A; Lerman LO
    J Am Soc Nephrol; 2004 Jul; 15(7):1816-25. PubMed ID: 15213269
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vivo renal vascular and tubular function in experimental hypercholesterolemia.
    Feldstein A; Krier JD; Sarafov MH; Lerman A; Best PJ; Wilson SH; Lerman LO
    Hypertension; 1999 Oct; 34(4 Pt 2):859-64. PubMed ID: 10523374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.